SCHEMBL2976451

SCHEMBL2976451

CCC(O)c1ccc(O)c(O)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 3/20 0.46
ADRA2A P08913 2/20 0.46
ADRA2B P18089 2/20 0.46
ADRA2C P18825 2/20 0.46
ADRA1A P35348 2/20 0.46
ADRA1B P35368 1/20 0.46
ADRB1 P08588 2/20 0.42
ADRB3 P13945 1/20 0.42
TSHR P16473 1/20 0.42
PDE2A O00408 1/20 0.41
LMNA P02545 1/20 0.40
RORC P51449 1/20 0.39
BCHE P06276 1/20 0.37
TYR P14679 1/20 0.37
ACHE P22303 1/20 0.37
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22432695 0.83 TYR (0.41) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL2382143 0.83 TSHR (0.57) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL272404 0.82 BCHE (0.46) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL2989016 0.81 TSHR (0.55) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL2980902 0.76 LMNA (0.41) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL22854146 0.75 TSHR (0.39) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL24217828 0.75 ADRB2 (0.42) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL2989000 0.75 ADRB2 (0.42) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL30046916 0.75 ADRB2 (0.42) ADRB2ADRA2AADRA2BADRA2CADRA1A
SCHEMBL28987486 0.74 ADRB2 (0.39) ADRB2ADRA2AADRA2BADRA2CADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109219593-B Maleimide compound containing substituted or unsubstituted allyl group, process for producing the same, and composition and cured product using the same DIC株式会社 2022-04-22 CN disclosed
CN-109312024-B Maleimide compound containing substituted or unsubstituted allyl group, process for producing the same, composition using the maleimide compound, and cured product DIC株式会社 2021-09-07 CN disclosed
US-7777073-B2 Topical delivery system for antiaging and skin whitening agents BIODERM RESEARCH (US) 2010-08-17 US disclosed
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents TYR, MMP17, MMP1 ADRB2 1017/4885ADRA2A 944/4885ADRA2B 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.